Functional characterization of the novel antipsychotic iloperidone at human D2, D3, α2C, 5-HT6, and 5-HT1A receptors
- 18 July 2003
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 73 (9), 1151-1159
- https://doi.org/10.1016/s0024-3205(03)00419-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Extended Radioligand Binding Profile of Iloperidone A Broad Spectrum Dopamine/Serotonin/Norepinephrine Receptor Antagonist for the Management of Psychotic DisordersNeuropsychopharmacology, 2001
- An assessment of iloperidone for the treatment of schizophreniaExpert Opinion on Investigational Drugs, 2000
- Binding of antipsychotic drugs to human brain receptorsLife Sciences, 2000
- Design and Synthesis of trans-N-[4-[2-(6-Cyano-1,2,3,4-tetrahydroisoquinolin-2- yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A Potent and Selective Dopamine D3 Receptor Antagonist with High Oral Bioavailability and CNS Penetration in the RatJournal of Medicinal Chemistry, 2000
- The Role of Serotonin in Antipsychotic Drug ActionNeuropsychopharmacology, 1999
- [3H]WAY–100635 for 5–HT1A receptor autoradiography in human brain: a comparison with [3H]8–OH–DPAT and demonstration of increased binding in the frontal cortex in schizophreniaNeurochemistry International, 1997
- Linking the Family of D2 Receptors to Neuronal Circuits in Human Brain: Insights into SchizophreniaNeuropsychopharmacology, 1997
- The Neural Correlates of the Noradrenergic Modulation of Human Attention, Arousal and LearningEuropean Journal of Neuroscience, 1997
- Novel dopamine receptors half a decade laterTrends in Pharmacological Sciences, 1995
- Pharmacological Manipulations of the ??2-Noradrenergic SystemDrugs & Aging, 1994